Back to Journals » Drug, Healthcare and Patient Safety
Drug, Healthcare and Patient Safety
Editor-in-Chief: Professor Rajender Aparasu
An international, peer reviewed, open access journal exploring patient safety issues in the healthcare continuum from diagnostic and screening interventions through to treatment, drug therapy and surgery. The journal is characterized by the rapid reporting of reviews, original research, clinical, epidemiological and post-marketing surveillance studies, risk management, health literacy and educational programs across all areas of healthcare delivery. Also, guidelines on data requirements to assure acceptable safety levels in license applications, and post marketing protocols on monitoring safety on managing associated morbidity and mortality are key topics. Adverse reaction case reports, animal and in vitro toxicity studies are also welcome. Balancing risk, effectiveness, patient satisfaction and quality of life and the development and testing of new interventions to optimize clinical outcomes in disease management are major areas of interest for the journal.
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
This journal offers Accelerated Publication.
Articles:
- View all (328)
- Volume 18, 2026 (14)
- Volume 17, 2025 (21)
- Volume 16, 2024 (15)
- Volume 15, 2023 (16)
- Volume 14, 2022 (19)
- Volume 13, 2021 (25)
- Volume 12, 2020 (35)
- Volume 11, 2019 (15)
- Volume 10, 2018 (12)
- Volume 9, 2017 (11)
- Volume 8, 2016 (13)
- Volume 7, 2015 (20)
- Volume 6, 2014 (22)
- Volume 5, 2013 (23)
- Volume 4, 2012 (18)
- Volume 3, 2011 (15)
- Volume 2, 2010 (25)
- Volume 1, 2009 (9)
Latest articles:
- 5 records -
Computed Tomography Diagnostic Reference Levels Worldwide and in Jordan: Implications for Patient Dose Reduction
Oglat AA, Shdaifat S, Sayah MA, Abukonna A, Khogali WMA
Drug, Healthcare and Patient Safety 2026, 18:595721
Published Date: 2 May 2026
Exosome Therapy for Livedoid Vasculitis Following COVID-19 Vaccination: A Case Report
Lin TK, Chang CF, Jong GP
Drug, Healthcare and Patient Safety 2026, 18:596013
Published Date: 1 May 2026
Diagnostic Challenges in a Pediatric Case of Recurrent Blistering Skin Reactions: Ibuprofen-Induced Fixed Drug Exanthema versus Infection-Triggered Erythema Multiforme
Möhrle R, Toni I, Wagner N, Schliep S, Hoerning A, Neubert A
Drug, Healthcare and Patient Safety 2026, 18:584720
Published Date: 23 April 2026
Trends and Types of Medical Errors Reporting Following the Implementation of Electronic Health Record System
A’aqoulah A, Alqahtani M, Bin Dayel DF, Zarbah B, Kalmey F, Shattat G, Abusaris R
Drug, Healthcare and Patient Safety 2026, 18:558973
Published Date: 1 April 2026
Trend of Reported Bleeding in Warfarin Compared with Direct Oral Anticoagulants in Japan
Takami A, Terashima G, Tajima T, Yamashita K, Igarashi A
Drug, Healthcare and Patient Safety 2026, 18:601538
Published Date: 30 March 2026
